Published in Arch Dermatol on August 01, 1999
Hepatitis C virus infection and its rheumatologic implications. Gastroenterol Hepatol (N Y) (2014) 0.82
Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol (2012) 0.77
Mononeuritis multiplex and painful ulcers as the initial manifestation of hepatitis B infection. BMJ Case Rep (2013) 0.75
Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis. Clin Rev Allergy Immunol (2017) 0.75
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol (1993) 5.51
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg (1996) 5.05
Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol (2007) 4.61
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol (2001) 4.34
Controlled study of malathion and d-phenothrin lotions for Pediculus humanus var capitis-infested schoolchildren. Lancet (1995) 4.16
Cultivation of the bacillus of Whipple's disease. N Engl J Med (2000) 3.97
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Liver fibrosis in overweight patients. Gastroenterology (2000) 3.56
Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol (2001) 3.41
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol (2000) 3.06
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med (1997) 3.01
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis (2013) 2.99
Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet (1998) 2.89
Case Records of the Massachusetts General Hospital--a home-court advantage? N Engl J Med (1995) 2.70
Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol (2000) 2.67
Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet (2002) 2.65
HIV infection en route to endogenization: two cases. Clin Microbiol Infect (2014) 2.63
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost (2000) 2.45
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol (2013) 2.38
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology (1999) 2.36
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 2.35
Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology (2001) 2.29
The key role of nucleosomes in lupus. Arthritis Rheum (1999) 2.26
Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol (1995) 2.16
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS (2001) 2.12
Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology (1999) 2.11
Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med (1996) 2.10
Reducing unnecessary laboratory use with new test request form: example of tumour markers. Lancet (1993) 2.08
Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol (2001) 2.04
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol (1992) 2.01
[Drug surveillance and topical drugs]. Ann Dermatol Venereol (1996) 2.01
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Skin pigmentary anomalies and mosaicism for an acentric marker chromosome originating from 3q. J Med Genet (1999) 2.00
Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol (1995) 1.98
Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol (1992) 1.94
Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol (1995) 1.85
ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther (2010) 1.83
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum (1999) 1.77
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol (2003) 1.73
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet (2000) 1.70
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol (1987) 1.69
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology (1994) 1.69
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
[Erysipelas: epidemiological, clinical and therapeutic data (111 cases)]. Ann Dermatol Venereol (1991) 1.66
Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr (2005) 1.66
Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology (2005) 1.65
Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. Arch Dermatol (1995) 1.64
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol (2001) 1.64
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology (1993) 1.64
Pacemaker infective endocarditis. Am J Cardiol (1998) 1.62
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol (1987) 1.62
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol (2013) 1.60
Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci (2001) 1.59
Neurological complications of neurofibromatosis type 1 in adulthood. Brain (1999) 1.58
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther (2007) 1.58
Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation (2000) 1.58
Pachydermodactyly and atrophia maculosa varioliformis cutis. Dermatology (1995) 1.57
Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients. Arch Dermatol (1994) 1.57
The significance of a single periungual fibroma: report of seven cases. Arch Dermatol (1995) 1.56
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum (1997) 1.55
Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) (1990) 1.55
Intractable hiccup as the initial presenting feature of systemic lupus erythematosus. Lupus (2005) 1.53
Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum (2000) 1.52
Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol (2001) 1.50
Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. Arch Dermatol (1996) 1.50
Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol (2001) 1.49
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med (1991) 1.49
Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol (1996) 1.48
Chloroquine-quinacrine association in resistant cutaneous lupus. Dermatology (1995) 1.46
A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol (2001) 1.46
Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol (1997) 1.46